Abstract: Orally disintegrating tablets containing colored granules of a water-soluble sugar which give them a speckled appearance are described. The orally disintegrating tablets with speckled appearance are readily and easy identifiable by physicians, nurses and patients.

Abstract: A packaging includes a tray and a sheet. The tray has a series of spaced apart sections. Each spaced apart section is generally rectangular in shape and has a recessed compartment and an upper surface. The sheet is fixed in part to the upper surface of the tray and has a plurality of tab portions that are not fixed to the tray thereby creating a tab. Each tab portion corresponds to one of the spaced apart sections and has first and second ends. Each tab portion can be graduated in width from the first end to the second end. The first end can be positioned in a corner of the corresponding spaced apart section. The tab portion has a length measured parallel to the length of the corresponding spaced apart section and the second end is adjacent to the sealed portion of the sheet.

Abstract: A solid dosage form of meloxicam containing an acid and sugars or polyalcohols or a mixture thereof.

Abstract: An orally disintegrating tablet which can be chewed or disintegrated by contact with saliva and containing weight-loss drugs for weight control in humans, especially in children and adolescents, is disclosed.

Abstract: Disclosed is a pharmaceutical composition in the form of a tablet suitable for dissolution in the buccal cavity, said composition comprising i) an effective amount of a narcotic active ingredient, and ii) a pharmaceutically acceptable amine having a pK of about 8 or greater, wherein the molar ratio of amine:active ingredient is at least about 5:1.

Abstract: The present invention provides solid dosage formulations of narcotic drugs with improved buccal adsorption. These improved characteristics are provided by the combination of the narcotic drug with an additional non-toxic soluble organic compound. The soluble organic compound contains a primary, secondary or tertiary amine group. The addition of this organic compound favorably alters the kinetics of mucosal penetration such that mucosal penetration times are decreased. This provides for a faster onset of action of the drug.

Abstract: A tablet punch having a punch cup having a non-stick polymeric coating which may comprise a fluoropolymer such as polytetrafluoroethylene.

Abstract: The present invention relates to a multipurpose system for the automatic washing and drying of industrial containers and appliances, in controlled environmental conditions.

Abstract: A packaging having a tray (12) having at least one recess to receive contents therein and an upper layer. The packaging also has a manually removable sheet (16) that is fixed in part to the upper layer of the tray and unfixed in part to the tray, the unfixed part of the sheet being in the form of a tab (20). The tab is located adjacent to one corner of the upper portion of the tray that forms the recess, whereby when the sheet is fixed to the tray it is an effective seal against moisture and light. The packaging may have a peel off layer that may be manually removed for those with limited dexterity. The tab has a graduated width for easy grasping by the patient The tray does not need to be separated into subsections prior to removal of the contents therein.

Abstract: The present invention is a method for forming a composition in solid particulate form from a mixture of constituents, at least one of which is a liquid, the method comprising forming said composition from a mixture of constituents comprising a lipophilic liquid, a hydrophilic solid dispersant, and a solid particulating agent.

Abstract: The present invention relates to a multipurpose system for the automatic washing and drying of industrial containers and appliances, in controlled environmental conditions.

Abstract: The application discloses oral pharmaceutical compositions which are tasted in the mouth during administration. Fast-dissolving tablets, chewable tablets and effervescent dispersions are exemplified. To mask the taste of unpleasant-tasting active ingredients, it has been found that blending with cyclodextrin without the conventional complex formation is effective. Consequently more economical modes of manufacture such as simple granulation and dry blending can be used.

Abstract: A liquid pharmaceutical composition for oral use containing 2-(4-isobutylphenyl)-propionic acid, as the active ingredient, and arginine is described.

Abstract: The present invention relates to a solid pharmaceutical composition containing (S)-2-(4-isobutylphenyl) propionic acid as active ingredient and it relates to a solid pharmaceutical composition suitable for the preparation of pharmaceutical forms in tablets, sachets and capsules containing (S)-2-(4-isobutylphenyl)-propionic acid as active ingredient. This formulation in tablets contains (S)-Ibupropen, colloidal silica as disintegrating agent, microcrystalline cellulose as diluent and magnesium stearate as lubricant. Tablets are prepared by direct compression of the pharmaceutical composition object of the present invention and may be coated or filmed according to conventional techniques.

Abstract: A syrup containing N-acetyl-cysteine, stable for at least two years, having pleasant taste and smell, consists of an aqueous solution of NAC, a sweetening agent and a thickening agent. The solution can also contain a flavoring agent and a preservative. The pH is between 5 and 8.

Abstract: A pharmacuetical composition in the form of cream, foam or stick containng 2.5-10% by weight (S)-2-(4-isobutylphenyl)propionic acid, 20-30% by weight and ethanol and 5-50% by weight propylene glycol, the ratio of ethanol to propylene glycol being 0.6-1 to 4:1.

Abstract: Pharmaceutical compositions having analgesic activity containing (S)-2-(6-methoxy-2-naphthyl)-propionic acid as active ingredient and arginine, useful for the preparation of pharmaceutical forms for oral route, are described,

Abstract: A pharmaceutical composition for oral use having analgesic activity containing a mixture of arginine and (S)-Ibuprofen in a molar ratio between 1.1 and 1.9 is described.

Abstract: An ophthalmic pharmaceutical composition containing an association of N-acetyl-cysteine and polyvinylalcohol useful for the treatment of keratoconjunctivitis sicca.

Abstract: A pharmaceutical composition for oral use containing the salt of S(+)-2-(4-isobutylphenyl)propionic acid with a basic aminoacid selected between L-arginine and L-lysine is described.